Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F135 - Redness and Rosacea

Monday, February 19; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe clinical features of rosacea
  • Recognize skin diseases other than rosacea that can produce facial redness
  • Develop an appropriate plan to manage facial redness

Description

Rosacea is a common inflammatory skin disease. Various subtypes of rosacea will be discussed and compared to other dermatologic processes that can produce facial redness. A large part of the session involves case-based presentation. Established and emerging treatments for rosacea and facial erythema will be presented. This activity has been approved by the American Board of Dermatology (ABD) for up to 20 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.

Disclosures

  • Helfrich, Yolanda Rosi, MD: Biogen – I(Grants/Research Funding); Boehringer Ingelheim – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Novartis – I(Grants/Research Funding);
Event Details
  • Date
    Monday, February 19
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 28A
  • CME Credits
    2.00
  • Type
    MOC
Directors/Co-Directors
  • Yolanda Rosi Helfrich, MD, FAAD